A Systematic Review on Rhodomyrtus Tomentosa (Aiton) Hassk: A Potential Source of Pharmacological Relevant Bioactive Compounds with Prospects as Alternative Remedies in Varied Medical Conditions

DOI:

https://doi.org/10.37285/ijpsn.2022.15.2.7

Authors

  • Ozioma Forstinus Nwabor Division of Infectious Diseases, Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, 90112, Thailand
  • Sudarshan Singh

Abstract

Rhodomyrtus tomentosa is a medicinal plant with vast phytochemical diversity. Its major bioactive constituents include acylphloroglucinols, terpenoids, polyphenol, and flavonoids. Phytochemicals form the plant possess a wide range of biological activities and many are prospect as possible alternative compounds for the management of various health disorders. The review presents the antimicrobial mechanism of action of extracts from the plant and its derivative compounds as reported by published research articles. The search showed that 126 documents have been published on the chemical composition and bioactivities of the plant, in addition, 35 documents were published on rhodomyrtone, the major bioactive acylphloroglucinol from the plant. Retrieved data suggested that the plant is rich in bioactive phytochemicals including rhodomyrtone and its derivatives, Myricitrin, Piceatannol, quercetin, dihydromyricetin, kaempferol, and vitexin. Furthermore, antimicrobial assays indicated that the plant is a source of effective antimicrobial compounds with various mechanisms of action. This paper reviews current knowledge the chemical composition, pharmacology, and toxicology of the plant and its principal compound. The review is intended to inform scientists with interested in drug development on the excellent qualities of the plant and to encourage further research aimed at shedding light on its medical relevance, biocompatibility, pharmacology, and pharmacokinetics.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Keywords:

Rhodomyrtus tomentosa, Rhodomyrtone, Antibiotic, Phytochemicals, Antimicrobial, Antioxidant, Anti-inflammatory

Downloads

Published

2022-04-30

How to Cite

1.
Forstinus Nwabor O, Singh S. A Systematic Review on Rhodomyrtus Tomentosa (Aiton) Hassk: A Potential Source of Pharmacological Relevant Bioactive Compounds with Prospects as Alternative Remedies in Varied Medical Conditions. Scopus Indexed [Internet]. 2022 Apr. 30 [cited 2024 Jun. 14];15(2):5875-91. Available from: https://www.ijpsnonline.com/index.php/ijpsn/article/view/2401

Issue

Section

Review Articles

References

Azizah AB Karem, Kamarudin E, Jusril NA, Halim H, Hussain RM, Bahari M (2021). In vitro cytotoxicity and antioxidant study of Rhodomyrtus tomentosa (Aiton) Hassk. ethanolic leaf extract on LPS-induced RAW 264.7 Macrophage Cells. J Pharm Res Int 33, 41–52.

ABD Hamid H, Mutazah R, Yusoff M M, ABD Karim N A and Abdull Razis AF (2017). Comparative analysis of antioxidant and antiproliferative activities of Rhodomyrtus tomentosa extracts prepared with various solvents. Food Chem Tox 108, 451–457.

Alexander C (2007). A tropical garden flora: plants cultivated in the Hawaiian Islands and other tropical places. George W. Staples & Derral R. Herbst. Bishop Museum, Honolulu, Hawai'i: Bishop Museum Press. 2005. 918 pp. Edinburgh Journal of Botany 64, 113–114.

Bray F, Ferlay J, Soerjomataram I, Siegel R L, Torre LA and Jemal A (2018). Cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68, 394–424.

Cai, Y and Geng H (2016). Chemical Constituents from the Roots of Rhodomyrtus tomentose. J Chin Med Mat 39, 1303–1307.

Chain EPO CITF, Schrenk D., Bignami M, Bodin L, Chipman JK, Del Mazo J, Grasl‐Kraupp B, Hogstrand C, Hoogenboom L and Leblanc JC (2019). Evaluation of the health risks related to the presence of cyanogenic glycosides in foods other than raw apricot kernels. EFSA Journal 17, e05662.

Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, LI Y, Wang X and Zhao L (2018). Inflammatory responses and inflammation-associated diseases in organs. Oncotarget 9, 7204.

Chorachoo J, Amnuaikit T and Voravuthikunchai SP (2013). Liposomal encapsulated rhodomyrtone: A novel antiacne drug. Evidence-Based Comp Alter Med Article ID157635.

Chorachoo J, Lambert S, Furnholm T, Roberts L, Reingold L, Auepemkiate S, Voravuthikunchai SP and Johnston A (2018). The small molecule rhodomyrtone suppresses TNF-∞ and IL-17A-induced keratinocyte inflammatory responses: A potential new therapeutic for psoriasis. PLoS ONE, 13.

Chorachoo J, Saeloh D, Srichana T, Amnuaikit T, Musthafa KS, Sretrirutchai S and Voravuthikunchai SP (2016). Rhodomyrtone as a potential anti-proliferative and apoptosis inducing agent in HaCaT keratinocyte cells. Eur J Pharm 772, 144-151.

Cui C, Zhang S, You L, Ren J, Luo W, Chen W and Zhao M (2013). Antioxidant capacity of anthocyanins from Rhodomyrtus tomentosa (Ait.) and identification of the major anthocyanins. Food Chem 139, 1-8.

Dachriyanus Salni, Sargent MV, Skelton BW, Soediro I, Sutisna M, White AH and Yulinah, E (2002). Rhodomyrtone, an antibiotic from Rhodomyrtus tomentosa. Aust J Chem 55, 229–232.

Deng X, Wang XR and WU L (2020). Triketone-terpene meroterpenoids from the leaves of Rhodomyrtus tomentosa. Fitoterapia, 143.

Diaz GJ (2015). Toxicosis by plant alkaloids in humans and animals in Colombia. Toxins 7, 5408–5416.

Dwita LP, Dewanti E, Dwipa F, Ramadani IF and Mareta DS (2021). Rhodomyrtus tomentosa extract activity on diabetic wound. J Physics: Conf Ser 1933, 012002.

Endang Sri Purwanti Ningsih N, Muhammad Ikhwan Rizki, Windy Yuliana Budianto (2021). Potential antiseptic of Rhodomyrtus tomentosa leaves extract on healing wound in male wistar rats. Res J Pharm Tech 14, 3143–3148.

Ferlinahayati Alfarado D, Eliza and Untari B (2020). α-Glucosidase inhibitory and a Leptospermone derivative from Rhodomyrtus tomentosa. Indones J Chem 20, 307–313.

Geetha K, Patil V and Murugan V (2012). Hepatoprotective activity of aqueous alcoholic (70%) extract of Rhodomyrtus tomentosa (Aiton) Hassk against antitubercular drugs induced hepatic damage. Int J Green Pharm 6, 295-298.

Geetha KM, Sridhar C and Murugan V (2010). Antioxidant and gastroprotective activities of Rhodomyrtus tomentosa (Ait.)Hassk. Int J PharmTech Res 2, 283-291.

GU RH, LI P, Wang YZ, WU SB, Edward JK and Long CL (2018). Analysis of constituents from different parts of Rhodomyrtus tomentosa by HPLC-TOF-MS. Chinese Trad Herbal Drugs 49, 554–560.

Hasibuan R, Ilyas S and Hanum S (2015). Effect of leaf extract haramonting (Rhodomyrtus tomentosa) to lower blood sugar levels in mice induced by alloxan. Int J PharmTech Res 8, 284–291.

Hassanpour SH and Dehghani M (2017). Review of cancer from perspective of molecular. J Cancer Res Pract 4, 127–129.

Hiranrat A, Chitbankluoi W, Mahabusarakam W, Limsuwan S, Voravuthikunchai SP (2012a). A new flavellagic acid derivative and phloroglucinol from Rhodomyrtus tomentosa. Nat Prod Res 26, 1904–1909.

Hiranrat A and Mahabusarakam W (2008). New acylphloroglucinols from the leaves of Rhodomyrtus tomentosa. Tetrahedron 64, 11193–11197.

Hiranrat A, Mahabusarakam W, Carroll AR, Duffy S and Avery VM (2012b). Tomentosones A and B, hexacyclic phloroglucinol derivatives from the thai shrub Rhodomyrtus tomentosa. J Org Chem 77, 680–683.

Hiranrat W, Hiranrat A and Mahabusarakam W (2017). Rhodomyrtosones G and H, minor phloroglucinols from the leaves of Rhodomyrtus tomentosa. Phytochem Let 21, 25-28.

Hmoteh J, Syed Musthafa K, Pomwised R and Voravuthikunchai SP (2016b). Effects of Rhodomyrtus tomentosa extract on killing activity of human neutrophils and membrane integrity of enterohaemorrhagic Escherichia coli O157: H7. Molecules 21, 692.

Hue TS, Abdullah TL, Abdullah NAP and Sinniah UR (2015). Genetic variation in Rhodomyrtus tomentosa (Kemunting) populations from Malaysia as revealed by inter-simple sequence repeat markers. Genet Molecul Res 14, 16827–16839.

Ilyas S (2020). Histology of spleen after induction nanoherbal Rhodomyrtus tomentosa. Int Jf Ecophysiol 2, 70–74.

Islam R, Mamat Y, Ismayil I, Yan M, Kadir M, Abdugheny A, Rapkat H, Niyaz M, Ali Y and Abay S (2015). Toxicity of anthraquinones: differential effects of rumex seed extracts on rat organ weights and biochemical and haematological parameters. Phytotherapy Res 29, 777–784.

Jeong D, Yang WS, Yang Y, Nam G, Kim JH, Yoon DH, Noh, HJ, Lee S, Kim TW, Sung G. H and Cho JY (2013). In vitro and in vivo anti-inflammatory effect of Rhodomyrtus tomentosa methanol extract. J Ethnopharmacol 146, 205–213.

Joshi T, Singh AK, Haratipour P, Sah AN, Pandey AK, Naseri R, Juyal V and Farzaei MH (2019). Targeting AMPK signaling pathway by natural products for treatment of diabetes mellitus and its complications. J Cellular Physiol 234, 17212–17231.

Kuntorini EM, Nugroho LH, Maryani and Nuringtyas TR (2019). Anatomical structure, flavonoid content, and antioxidant activity of Rhodomyrtus tomentosa leaves and fruits on different age and maturity level. Biodiversitas 20, 3619–-3625.

Kusuma IW, Ainiyati N and Suwinarti W (2016). Search for biological activities from an invasive shrub species rosemyrtle (Rhodomyrtus tomentosa). Nusantara Biosci 8.

Lai TNH, André C, Rogez H, Mignolet E, Nguyen TBT and Larondelle Y (2015). Nutritional composition and antioxidant properties of the sim fruit (Rhodomyrtus tomentosa). Food chem 168, 410–416.

Lai TNH, André CM, Chirinos R, Nguyen TBT, Larondelle Y and Rogez H (2014). Optimisation of extraction of piceatannol from Rhodomyrtus tomentosa seeds using response surface methodology. Separat Purificat Tech 134, 139–146.

Langeland KA (2008). Identification and biology of nonnative plants in Florida's natural areas, IFAS Communication Services, University of Florida.

Lavanya G, Voravuthikunchai SP and Towatana NH (2012). Acetone extract from Rhodomyrtus tomentosa: A potent natural antioxidant. Evidence-based Complement Alternat Med Article ID 535479.

Leejae S, Hasap L and Voravuthikunchai SP (2013a). Inhibition of staphyloxanthin biosynthesis in Staphylococcus aureus by rhodomyrtone, a novel antibiotic candidate. J Medical Microbiol 62, 421–428.

Leejae S, Taylor PW and Voravuthikunchai SP (2013b). Antibacterial mechanisms of rhodomyrtone against important hospital-acquired antibiotic-resistant pathogenic bacteria. Journal of Medical Microbiol 62, 78–85.

Leejae S, Yingyongnarongkul BE, Suksamrarn A and Voravuthikunchai SP (2012). Synthesis and structure-activity relationship of rhodomyrtone derivatives as antibacterial agent. Chinese Chemical Letters 23, 1011–1014.

Lim T (2012). Myrtus communis. Edible medicinal and non medicinal plants. Springer.

Limsuwan S, Hesseling-Meinders A, Voravuthikunchai SP, Van Dijl JM and Kayser O (2011). Potential antibiotic and anti-infective effects of rhodomyrtone from Rhodomyrtus tomentosa (Aiton) Hassk. on Streptococcus pyogenes as revealed by proteomics. Phytomedicine 18, 934–940.

Limsuwan S, Homlaead S, Watcharakul S, Chusri S, Moosigapong K, Saising J and Voravuthikunchai SP (2014). Inhibition of microbial adhesion to plastic surface and human buccal epithelial cells by Rhodomyrtus tomentosa leaf extract. Archives Oral Bio 59, 1256–1265.

Limsuwan S, Kayser O and Voravuthikunchai SP (2012). Antibacterial activity of Rhodomyrtus tomentosa (Aiton) Hassk. Leaf extract against clinical isolates of streptococcus pyogenes. Evidence-based Complem Alternat Med Article ID 697183.

Limsuwan S, Trip EN, Kouwen TRHM, Piersma S, Hiranrat A, Mahabusarakam W, Voravuthikunchai SP, Van Dijl JM and Kayser O (2009). Rhodomyrtone: A new candidate as natural antibacterial drug from Rhodomyrtus tomentosa. Phytomed 16, 645–651.

Limsuwan S and Voravuthikunchai SP (2008). Boesenbergia pandurata (Roxb.) Schltr., Eleutherine americana Merr. and Rhodomyrtus tomentosa (Aiton) Hassk. as antibiofilm producing and antiquorum sensing in Streptococcus pyogenes. FEMS Immuno Medical Microbiol 53, 429–436.

Liu HX, Chen K, Yuan Y, Xu ZF, Tan HB and Qiu SX (2016a). Rhodomentones A and B, novel meroterpenoids with unique NMR characteristics from: Rhodomyrtus tomentosa. Organic Biomolecular Chem 14, 7354–7360.

Liu HX, Tan HB and Qiu SX (2016b). Antimicrobial acylphloroglucinols from the leaves of Rhodomyrtus tomentosa. J Asian Natural Prod Res 18, 535–541.

Liu HX, Zhang WM, Xu ZF, Chen YC, Tan HB and Qiu SX (2016c). Isolation, synthesis, and biological activity of tomentosenol A from the leaves of Rhodomyrtus tomentosa. RSC Advances 6, 25882–25886.

Luo D, Zhang YB, Huang J, Chen LF, He LJ, Kuang GK, Qin J, Li QG, Wang GC and Li YL (2019). One New Sesquiterpene from the Leaves of Rhodomyrtus tomentosa. Chemistry Let 48, 55–57.

MA SJ, YU J, Yan DW, Wang DC, Gao JM and Zhang Q (2018). Meroterpene-like compounds derived from β-caryophyllene as potent α-glucosidase inhibitors. Organic Biomolecular Chem 16, 9454–9460.

Maskam MF (2011). Antioxidant effects of Rhodomyrtus tomentosa (kemunting) extract on the development of experimental atherosclerotic-induced New zealand white rabbit. University of Malaya. Master thesis.

Maskam MF, Mohamad J, Abdulla MA, Afzan A and Wasiman I (2014). Antioxidant activity of Rhodomyrtus tomentosa (kemunting) fruits and its effect on lipid profile in induced-cholesterol New Zealand white rabbits. Sains Malaysiana 43, 1673–1684.

Mathers CD and Loncar D (2006). Projections of global mortality and burden of disease from 2002 to 2030. PLoS medicine 3, e442.

Matsuura HN and Fett-Neto AG (2015). Plant alkaloids: main features, toxicity, and mechanisms of action. Plant toxins 1-15.

Mitsuwan W, Jiménez-Munguía I, Visutthi M, Sianglum W, Jover A, Barcenilla F, et. al. (2019). Rhodomyrtone decreases Staphylococcus aureus SigB activity during exponentially growing phase and inhibits haemolytic activity within membrane vesicles. Microbial Pathog 128, 112–118.

Mitsuwan W, Olaya-Abril A, Calderón-Santiago M, Jiménez-Munguía I, González-Reyes J A, Priego-Capote F, Voravuthikunchai SP and Rodríguez-Ortega MJ (2017). Integrated proteomic and metabolomic analysis reveals that rhodomyrtone reduces the capsule in Streptococcus pneumoniae. Scientific reports 7, 1–13.

Mitsuwan W, Wintachai P and Voravuthikunchai SP (2020). Rhodomyrtus tomentosa leaf extract and rhodomyrtone combat Streptococcus pneumoniae biofilm and inhibit invasiveness to human lung epithelial and enhance pneumococcal phagocytosis by macrophage. Current Microbiol 1-9.

Mo Q, Zhou X, Huang S, Zhou Y, Mou J, Luo Q, Huang X, Yang X, Chen X and Liang C (2019). A new triterpenoid from the leaves of Rhodomyrtus tomentosa (Ait.) Hassk. Natural Product Res 35, 2289–2294.

Mordmuang A, Brouillette E, Voravuthikunchai SP and Malouin F (2019). Evaluation of a Rhodomyrtus tomentosa ethanolic extract for its therapeutic potential on Staphylococcus aureus infections using in vitro and in vivo models of mastitis. Veterinary Res 50.

Mordmuang A, Shankar S, Chethanond U and Voravuthikunchai SP (2015). Effects of Rhodomyrtus tomentosa leaf extract on staphylococcal adhesion and invasion in bovine udder epidermal tissue model. Nutrients 7, 8503–8517.

Mordmuang A and Voravuthikunchai SP (2015). Rhodomyrtus tomentosa (Aiton) Hassk. leaf extract: An alternative approach for the treatment of staphylococcal bovine mastitis. Research Vet Sci 102, 242–246.

Na-Phatthalung P, Chusri S, Suanyuk N and Voravuthikunchai SP (2017). In vitro and in vivo assessments of Rhodomyrtus tomentosa leaf extract as an alternative anti-streptococcal agent in nile tilapia (Oreochromis niloticus L.). J Medical Microbiol 66, 430–439.

Na-Phatthalung P, Teles M, Voravuthikunchai SP, Tort L and Fierro-Castro C (2018). Immunomodulatory effects of Rhodomyrtus tomentosa leaf extract and its derivative compound, rhodomyrtone, on head kidney macrophages of rainbow trout (Oncorhynchus mykiss). Fish Physiology Biochem 44, 543–555.

Nobili S, Lippi D, Witort E, Donnini M, Bausi L, Mini E and Capaccioli S (2009). Natural compounds for cancer treatment and prevention. Pharmacological Res 59, 365–378.

Noviani D, Treasa AD, Munaf AZT, Winarsih S, Hidayati DYN, Nooryanto M and Sutrisno S (2021). In vivo effect analysis of Rhodomyrtus tomentosa leaf ethanol extract against Escherichia coli. Medical Lab Tech J 7, 83–91.

Odedina GF, Vongkamjan K and Voravuthikunchai SP (2015). Potential bio-control agent from Rhodomyrtus tomentosa against Listeria monocytogenes. Nutrients 7, 7451–7468.

Odedina GF, Vongkamjan K and Voravuthikunchai SP (2016). Use of Rhodomyrtus tomentosa ethanolic leaf extract for the bio-control of Listeria monocytogenes post-cooking contamination in cooked chicken meat. J Food Sci Tech 53, 4234–4243.

Ontong JC, Singh S, Nwabor OF, Chusri S and Voravuthikunchai SP (2020). Potential of antimicrobial topical gel with synthesized biogenic silver nanoparticle using Rhodomyrtus tomentosa leaf extract and silk sericin. Biotech Letters 42, 2653–2664.

Qin XJ, Rauwolf TJ, Li PP, Liu H, Mcneely J, Hua Y, Liu HY and Porco JA JR (2019). Isolation and synthesis of novel meroterpenoids from Rhodomyrtus tomentosa: investigation of a reactive enetrione intermediate. Angewandte Chemie Int Edn 58, 4291–4296.

Manurung RD, Ilyas S, Hutahaean S, Rosidah R and Situmorang PC (2021). Diabetic wound healing in FGF expression by nano herbal of Rhodomyrtus tomentosa L. and Zanthoxylum acanthopodium fruits. Pak J Biol Sci 24, 401–408.

Sabrina T, Kamaluddin M, Theodorus T and Salni S (2021). The Effectiveness of karamunting leaf’s fraction (Rhodomyrtus tomentosa (Aiton) Hassk) as antimicrobials in carbapenemase resistant Klebsiella pneumonia. Sriwijaya J Med 4, 1–8.

Saeloh D, Tipmanee V, Jim KK, Dekker MP, Bitter W, Voravuthikunchai SP, Wenzel M and Hamoen LW (2018). The novel antibiotic rhodomyrtone traps membrane proteins in vesicles with increased fluidity. PLoS Pathogens 14.

Saeloh D, Tipmanee V and Voravuthikunchai SP (2016). Rhodomyrtone target exploration: computer aided search on Staphylococcus aureus key proteins as a potential therapeutic target. Current Computer-Aided Drug Design 12, 119–134.

Saeloh D, Wenzel M, Rungrotmongkol T, Hamoen LW, Tipmanee V and Voravuthikunchai SP (2017). Effects of rhodomyrtone on Gram-positive bacterial tubulin homologue FtsZ. PeerJ 5, e2962.

Saising J, Götz F, Dube L, Ziebandt AK and Voravuthikunchai SP (2015). Inhibition of staphylococcal biofilm-related gene transcription by rhodomyrtone, a new antibacterial agent. Annals of Microbiol 65, 659–665.

Saising J, Hiranrat A, Mahabusarakam W, Ongsakul M and Voravuthikunchai SP (2008). Rhodomyrtone from Rhodomyrtus tomentosa (Aiton) hassk. as a natural antibiotic for staphylococcal cutaneous infections. J Health Sci 54, 589–595.

Saising J, Ongsakul M and Voravuthikunchai SP (2011). Rhodomyrtus tomentosa (Aiton) Hassk. ethanol extract and rhodomyrtone: a potential strategy for the treatment of biofilm-forming staphylococci. J Medical Microbiol, 60, 1793–1800.

Saising J, Voravuthikunchai SP (2012). Anti Propionibacterium acnes activity of rhodomyrtone, an effective compound from Rhodomyrtus tomentosa (Aiton) Hassk. leaves. Anaerobe 18, 400–404.

Sang VT, Hung ND, Uyen LP, Nghiep ND and Se-Kwon K (2019). Investigation of the biological activities of phu quoc sim fruits Rhodomyrtus tomentosa (Aiton) hassk. EurAsian J BioSci 13, 49–55.

Senica M, Stampar F and Mikulic-Petkovsek M (2019). Harmful (cyanogenic glycoside) and beneficial (phenolic) compounds in different Sambucus species. J Berry Res 9, 395–409.

Shankar S, Leejae S, Jaiswal L and Voravuthikunchai SP (2017). Metallic nanoparticles augmented the antibacterial potency of Rhodomyrtus tomentosa acetone extract against Escherichia coli. Microbial Pathogen 107, 181–184.

Shiratake S, Nakahara T, Iwahashi H, Onodera T and Mizushina Y (2015). Rose myrtle (Rhodomyrtus tomentosa) extract and its component, piceatannol, enhance the activity of DNA polymerase and suppress the inflammatory response elicited by UVB-induced DNA damage in skin cells. Molecular Medicine Report 12, 5857–5864.

Sianglum W, Saeloh D, Tongtawe P, Wootipoom N, Indrawattana N and Voravuthikunchai SP (2018). Early effects of rhodomyrtone on membrane integrity in methicillin-resistant Staphylococcus aureus. Microbial Drug Resist 24, 882–889.

Sianglum W, Srimanote P, Taylor PW, Rosado H and Voravuthikunchai SP (2012). Transcriptome Analysis of Responses to Rhodomyrtone in Methicillin-Resistant Staphylococcus aureus. PLoS One 7.

Sianglum W, Srimanote P, Wonglumsom W, Kittiniyom K and Voravuthikunchai SP (2011). Proteome analyses of cellular proteins in methicillin-resistant Staphylococcus aureus treated with rhodomyrtone, a novel antibiotic candidate. PLoS One 6.

Sinulingga SE, Hasibuan PAZ and Suryanto D (2018). Antibacterial activity of karamunting (Rhodomyrtus tomentosa (aiton) hassk) leaf extract and fractions. Asian J Pharm Clinical Res 11, 163–165.

Siriyong T, Ontong JC, Leejae S, Suwalak S, Coote PJ and Voravuthikunchai SP (2020). In vivo safety assessment of rhodomyrtone, a potent compound, from Rhodomyrtus tomentosa leaf extract. Toxicology Reports 7, 919–924.

Srisuwan S, Mackin KE, Hocking D, Lyras D, Bennett-Wood V, Voravuthikunchai SP and Robins-Browne RM (2018). Antibacterial activity of rhodomyrtone on Clostridium difficile vegetative cells and spores in vitro. Int J Antimicrobial Agents 52, 724–729.

Srisuwan S, Tongtawe P, Srimanote P and Voravuthikunchai SP (2014). Rhodomyrtone modulates innate immune responses of THP-1 monocytes to assist in clearing methicillin-resistant Staphylococcus aureus. PloS one 9, e110321.

Srisuwan S and Voravuthikunchai SP (2017). Rhodomyrtus tomentosa leaf extract inhibits methicillin-resistant Staphylococcus aureus adhesion, invasion, and intracellular survival in human HaCaT keratinocytes. Microbial Drug Resist 23, 1002–1012.

Tayeh M, Nilwarangkoon S, Tanunyutthawongse C, Mahabusarakum W Watanapokasin R (2018). Apoptosis and antimigration induction in human skin cancer cells by rhodomyrtone. Experimental Therapeut Medicine 15, 5035–5040.

Tayeh M, Nilwarangoon S, Mahabusarakum W and Watanapokasin R (2017). Anti-metastatic effect of rhodomyrtone from Rhodomyrtus tomentosa on human skin cancer cells. International J Oncology 50, 1035–1043.

Tong XL, Wang HT, Xu JP and Tian LW (2020). A new polyhydroxylated oleanane triterpenoid from the roots of Rhodomyrtus tomentosa. Natural Product Res 34, 204–209.

Traithan A, Tongtawe P, Thanongsaksrikul J, Voravuthikunchai S and Srimanote P (2020). Antibacterial mechanism of rhodomyrtone involves the disruption of nucleoid segregation checkpoint in Streptococcus suis. AMB Express, 10.

Tung NH, Ding Y, Choi EM, Van Kiem P, Van Minh C and Kim YH (2009). New anthracene glycosides from Rhodomyrtus tomentosa stimulate osteoblastic differentiation of MC3T3-E1 cells. Archives of Pharmacal Res 32, 515–520.

Visutthi M, Srimanote P and Voravuthikunchai SP (2011). Responses in the expression of extracellular proteins in methicillin-resistant Staphylococcus aureus treated with rhodomyrtone. Journal of Microbiol 49, 956–964.

Vo TS, Kim YS, Ngo DN and Ngo DH (2019). The Role of Rhodomyrtus tomentosa (Aiton) Hassk. fruits in downregulation of mast cells-mediated allergic responses. BioMed Res Int Article ID 3505034.

Vo TS, Kim YS, Ngo DN and Ngo DH (2020a). Myricetin from Rhodomyrtus tomentosa (Aiton) Hassk fruits attenuates inflammatory responses in histamine-exposed endothelial cells. Process Biochem 92, 457–463.

Vo TS, Le TT, Kim SY and Ngo DH (2020b). The role of myricetin from Rhodomyrtus tomentosa (Aiton) Hassk fruits on downregulation of FcɛRI-mediated mast cell activation. J Food Biochem 44.

Vo TS, Le TT, Kim SY and Ngo DH (2020c). The role of myricetin from Rhodomyrtus tomentosa (Aiton) Hassk fruits on downregulation of FcɛRI‐mediated mast cell activation. J Food Biochem 44, e13143.

Voravuthikunchai SP, Dolah S and Charernjiratrakul W (2010). Control of Bacillus cereus in foods by Rhodomyrtus tomentosa (Ait.) Hassk. leaf extract and its purified compound. J Food Protection 73, 1907–1912.

Wagner WL, Herbst DR and Sohmer S (1999). Manual of the flowering plants of Hawai'i. Vol. 1, University of Hawaii Press.

Winotai A, Wright T and Goolsby JA (2005). Herbivores in Thailand on Rhodomyrtus tomentosa (Myrtaceae), an invasive weed in Florida. Florida Entomologist 88, 104–105.

Wu P, Ma G, Li N, Deng Q, Yin Y and Huang R (2015). Investigation of in vitro and in vivo antioxidant activities of flavonoids rich extract from the berries of Rhodomyrtus tomentosa (Ait.) Hassk. Food Chem 173, 194–202.

Wunnoo S, Bilhman S, Amnuaikit T, Ontong JC, Singh S, Auepemkiate S and Voravuthikunchai SP (2021). Rhodomyrtone as a new natural antibiotic isolated from Rhodomyrtus tomentosa leaf extract: A clinical application in the management of acne vulgaris. Antibiotics 10, 108.

Wunnoo S, Saising J and Voravuthikunchai SP (2017). Rhodomyrtone inhibits lipase production, biofilm formation, and disorganizes established biofilm in Propionibacterium acnes. Anaerobe 43, 61–68.

Xiong J, Huang Y, Tang Y, You M and Hu J (2013). Pentacyclic triterpenoids from the roots of Rhodomyrtus tomentosa. Chinese J Organic Chem 33, 1304–1308.

Xu L, Li Y, Dai Y and Peng J (2018). Natural products for the treatment of type 2 diabetes mellitus: pharmacology and mechanisms. Pharmacol Res 130, 451–465.

Yuan Y, Yu X, Chen Y, Zhang B and Deng Z (2018). Comparison of extracting methods for anthocyanins and flavonoids of Rhodomyrtus tomentosa and studies on their antioxidant activity. J Chinese Inst Food Sci Tech 18, 144–151.

Zeyohanness SS, Abd Hamid H and Zulkifli FH (2018). Poly(vinyl alcohol) electrospun nanofibers containing antimicrobial Rhodomyrtus tomentosa extract. J Bioactive Compatible Polym 33, 585–596.

Zhang X, Cheng J, He P, Zhu J, Chen Z, Miao S, Wang G, Jiang J and Wang Y (2020). Active monomer rtr-1 derived from the root of Rhodomyrtus tomentosa induces apoptosis in gastric carcinoma cells by inducing er stress and inhibiting the stat3 signaling pathway. Cancer Manag Res 12, 3117–3129.

Zhang YB, Li W, Jiang L, Yang L, Chen NH, Wu ZN, Li YL and Wang GC (2018). Cytotoxic and anti-inflammatory active phloroglucinol derivatives from Rhodomyrtus tomentosa. Phytochem 153, 111–119.

Zhang YB, Li W, Zhang ZM, Chen NH, Zhang XQ, Jiang JW, Wang GC and Li YL (2016a). Two new triterpenoids from the roots of Rhodomyrtus tomentosa. Chemistry Letters, 45, 368–370.

Zhang YL, Chen C, Wang XB, WU L, Yang MH, Luo J, Zhang C, Sun HB, Luo JG and Kong LY (2016b.) Rhodomyrtials A and B, Two Meroterpenoids with a Triketone-Sesquiterpene-Triketone Skeleton from Rhodomyrtus tomentosa: structural elucidation and biomimetic synthesis. Organic Let 18, 4068–4071.

Zhang YL, Zhou XW, Wu L, Wang XB, Yang MH, Luo J, Luo JG and Kong LY (2017). Isolation, structure elucidation, and absolute configuration of syncarpic acid-conjugated terpenoids from Rhodomyrtus tomentosa. J Natural Products 80, 989–998.

Zhao LY, Liu HX, Wang L, Xu ZF, Tan HB and Qiu SX (2019). Rhodomyrtosone B, a membrane-targeting anti-MRSA natural acylgphloroglucinol from Rhodomyrtus tomentosa. J Ethnopharmacol 228, 50–57.

Zhao Z, Wu L, Xie J, Feng Y, Tian J, He X, Li B, Wang L, Wang X and ZHANG, Y. 2020. Rhodomyrtus tomentosa (Aiton.): A review of phytochemistry, pharmacology and industrial applications research progress. Food chemistry, 309, 125715.

Zhou XM, Liu HX, Chen S, Ju XC, Tan HB, Qiu SX and Zheng C (2016a). Chemical constituents from leaves of Rhodomyrtus tomentosa. Chinese Trad Herbal Drugs 47, 2614–2620.

Zhou Y, Hong Y and Huang H (2016b). Triptolide attenuates inflammatory response in membranous glomerulo-nephritis rat via downregulation of NF-κB signaling pathway. Kidney Blood Pressure Res 41, 901–910.

Zhuang L, Chen LF, Zhang YB, Liu Z, Xiao XH, Tang W, Wang GC, Song WJ, Li, YL and Li MM (2017). Watsonianone A from Rhodomyrtus tomentosa fruit attenuates respiratory-syncytial-virus-induced inflammation in vitro. J Agricultural Food Chem, 65, 3481–3489.

Most read articles by the same author(s)

1 2 > >>